GBECAM 0115 – AMAZONA III | Prospective evaluation of breast cancer at Brazilian institutions – Project AMAZONA III
LACOG 0221 – BRAVE | Real-World Data on First-line Treatment of Hormone Receptor-positive, HER2-negative, Metastatic Breast Cancer in Brazil (LACOG 0221) – BRAVE Study
LACOG 0413 – Male Breast Cancer | Clinical and biological characterization of Male Breast Cancer: an international EORTC, BIG, TBCRC and NABCG intergroup study.
LACOG 0615 – LATINABreast | A study to observe patients characteristics, treatment patterns and outcomes in patients with newly diagnosed breast cancer in Latin America.
LACOG 0119 | Multicenter retrospective database on prognostic and predictive factors in patients with neuroendocrine tumors
LACOG 0222 – GASPAR | Epidemiological characteristics of gastric and pancreatic cancers in Latin America OPEN FOR RECRUITMENT
LACOG 0421 – ACTION HIV | ACTION HIV (Anal Cancer TherapIes and Outcomes iNitiative for patients living with and without HIV): A global record of patients with anal squamous cell carcinoma with and without HIV infection. OPEN FOR RECRUITMENT
LACOG 0121 – PET-PSMA | Retrospective analysis of 68Ga-PSMA-PET in patients with prostate cancer: experience from Brazil (LACOG pPR015)
LACOG 0217 – IRONMAN | Prostate Cancer Outcomes: An International Registry to Improve Outcomes in Men with Advanced Prostate Cancer
LACOG 1120 – RENAL REGISTRY | Clinicopathological characteristics and outcomes of patients with Renal Cell Carcinoma in Latin America
LACOG 1818 – Prostate Cancer Registry | Survival outcomes in metastatic prostate cancer in the Brazilian population – analysis of individual characteristics and treatment modalities in different national health institutions
LACOG 0521 – MADONNA | Molecular and epidemiological characteristics of endometrial cancer in Brazil OPEN FOR RECRUITMENT
LACOG 0820 – EVITA LATAM | Epidemiological Landscape of Cervical Cancer in Latin America
LACOG 1220 – CONOR | CONOR: A Collaborative trial of Niraparib to evaluate patients with Ovarian cancer in the expanded access program in Latin America
LACOG 0319 | Quality Of Life Assessment Study In Patients With Metastatic Head And Neck Neoplasia Submitted To Immunotherapy In Brazil OPEN FOR RECRUITMENT
LACOG 0116 – LATINO LUNG | Prospective epidemiological study of metastatic Non Small Cell Lung Cancer (NSCLC) in Latin America
LACOG 0118 – RELANCE | Retrospective epidemiological study of Locally Advanced Non Small Cell Lung Cance
LACOG 0120 – EAP durva lung cancer | Durvalumab as maintenance in patients who received chemoradiotherapy for unresectable stage III NSCLC: Real World Data from an Expanded Access Program in Brazil.
LACOG 0322 – EDUR-BRA | A Real-World Assessment of the demographic, clinical characteristics and outcomes of a Brazilian cohort of Previously Untreated Extensive Stage-Small Cell Lung Cancer receiving Durvalumab combined with Platinum-Etoposide in (ES-SCLC) in Brazil. OPEN FOR RECRUITMENT
LACOG 1918 | Patient Journey with advanced lung cancer positive for ALK fusion in Brazil
LACOG 0122 – RADIANT | Extreme hypofractionation radiotherapy in patients with breast cancer in Brazil: retrospective cohort study OPEN FOR RECRUITMENT
